1. Circulating human papillomavirus DNA as a surveillance tool in head and neck squamous cell carcinoma: A systematic review and meta-analysis
   K.K. Jensen et al, 2018, Clin Otolaryngol CrossRef
2. Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker
   Wai Kei Jacky Lam et al, 2019, J. Pathol. CrossRef
3. Molecular Prognostic Value of Circulating Epstein–Barr Viral DNA in Nasopharyngeal Carcinoma: A Meta-Analysis of 27,235 Cases in the Endemic Area of Southeast Asia
   Xulin Xie et al, 2019, Genetic Testing and Molecular Biomarkers CrossRef
4. Increasing the accuracy and scalability of the Immunofluorescence Assay for Epstein Barr Virus by inferring continuous titers from a single sample dilution
   Sherry Meow Peng Goh et al, 2017, Journal of Immunological Methods CrossRef
5. In Regard to Kim et al
   Teuta Zoto Mustafayev et al, 2017, International Journal of Radiation Oncology*Biology*Physics CrossRef
6. Prognostic value of Epstein–Barr virus DNA level for nasopharyngeal carcinoma: a meta-analysis of 8128 cases
   Hongling Qu et al, 2019, Eur Arch Otorhinolaryngol CrossRef
7. Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location
   N. B. Senyuta et al, 2019, Voprosy virusologii CrossRef
8. Validation of a Highly Sensitive qPCR Assay for the Detection of Plasma Cell-Free Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma Diagnosis
   Vu Nguyen Quynh Anh et al, 2020, Cancer Control CrossRef
9. Pathology of HPV-Associated Head and Neck Carcinomas: Recent Data and Perspectives for the Development of Specific Tumor Markers
   Xavier Sastre-Garau et al, 2020, Front. Oncol. CrossRef
10. Long‐term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma
    Wanxia Li et al, 2020, Cancer Med CrossRef
11. Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein–Barr virus DNA
    Zhi‐Gong Wei et al, 2021, Head & Neck CrossRef
12. null
    Jin-Ching Lin, 2021 CrossRef
13. A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma
    Anne W.M. Lee et al, 2021, European Journal of Cancer CrossRef
14. Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature
    Chi Leung Chiang et al, 2021, Front. Oncol. CrossRef
15. Cell‐free EBV DNA as a biomarker during clinical management of nasopharyngeal carcinoma in a nonendemic region
    Raja Pramanik et al, 2021, J Med Virol CrossRef
16. Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma
    Nasser Al-Rajhi et al, 2021 CrossRef
17. Polymerase Chain Reaction for Prognosis Assessment and Monitoring of the Epstein-Barr Virus-Associated Hodgkin’s Lymphoma
    M.A. Katsin et al, 2018, Клиническая онкогематология CrossRef
18. Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma
    D.C.T. Chan et al, 2022, Annals of Oncology CrossRef
19. EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA: VIRAL MARKERS FOR DIAGNOSTICS AND ASSESSMENT OF CLINICAL STATUS OF PATIENTS
    V. N. Kondratova et al, 2018, Problems of Virology CrossRef
20. The Promise of Circulating Tumor DNA in Head and Neck Cancer
    Sukhkaran S. Aulakh et al, 2022, Cancers CrossRef
21. Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA
    Xiaofei Yuan et al, 2022, BMC Cancer CrossRef
22. High plasma EBV-DNA load and positive EBER status associated with viral recurrence and persistent infection in early treatment of lymphoma
    Meichun Zeng et al, 2022, Clin Exp Med CrossRef
23. Development and validation of a joint model for dynamic prediction of overall survival in nasopharyngeal carcinoma based on longitudinal post-treatment plasma cell-free Epstein-Barr virus DNA load
    Guang-Li Zhu et al, 2022, Oral Oncology CrossRef
24. The Dynamic Change in Plasma Epstein–Barr Virus DNA Load over a Long-Term Follow-Up Period Predicts Prognosis in Nasopharyngeal Carcinoma
    Amina Gihbid et al, 2022, Viruses CrossRef
25. Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology
    Noah Earland et al, 2023, Seminars in Radiation Oncology CrossRef
26. null
    Jin-Ching Lin, 2023 CrossRef